Spruce Biosciences Statistics
Total Valuation
SPRB has a market cap or net worth of $16.52 million. The enterprise value is -$40.30 million.
Important Dates
The last earnings date was Monday, November 11, 2024, before market open.
Earnings Date | Nov 11, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SPRB has 41.30 million shares outstanding. The number of shares has increased by 20.12% in one year.
Current Share Class | 41.30M |
Shares Outstanding | 41.30M |
Shares Change (YoY) | +20.12% |
Shares Change (QoQ) | +0.34% |
Owned by Insiders (%) | 14.44% |
Owned by Institutions (%) | 12.91% |
Float | 21.75M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.31 |
Forward PS | n/a |
PB Ratio | 0.32 |
P/TBV Ratio | 0.32 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.36, with a Debt / Equity ratio of 0.06.
Current Ratio | 5.36 |
Quick Ratio | 5.06 |
Debt / Equity | 0.06 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -121.12 |
Financial Efficiency
Return on equity (ROE) is -57.55% and return on invested capital (ROIC) is -37.20%.
Return on Equity (ROE) | -57.55% |
Return on Assets (ROA) | -30.35% |
Return on Capital (ROIC) | -37.20% |
Revenue Per Employee | $244,862 |
Profits Per Employee | -$1.36M |
Employee Count | 29 |
Asset Turnover | 0.08 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.36% in the last 52 weeks. The beta is 2.34, so SPRB's price volatility has been higher than the market average.
Beta (5Y) | 2.34 |
52-Week Price Change | -74.36% |
50-Day Moving Average | 0.50 |
200-Day Moving Average | 0.67 |
Relative Strength Index (RSI) | 36.54 |
Average Volume (20 Days) | 885,289 |
Short Selling Information
The latest short interest is 30,676, so 0.07% of the outstanding shares have been sold short.
Short Interest | 30,676 |
Short Previous Month | 71,034 |
Short % of Shares Out | 0.07% |
Short % of Float | 0.14% |
Short Ratio (days to cover) | 0.10 |
Income Statement
In the last 12 months, SPRB had revenue of $7.10 million and -$39.43 million in losses. Loss per share was -$0.96.
Revenue | 7.10M |
Gross Profit | -28.96M |
Operating Income | -43.24M |
Pretax Income | -46.75M |
Net Income | -39.43M |
EBITDA | -43.19M |
EBIT | -43.24M |
Loss Per Share | -$0.96 |
Full Income Statement Balance Sheet
The company has $60.06 million in cash and $3.23 million in debt, giving a net cash position of $56.83 million or $1.38 per share.
Cash & Cash Equivalents | 60.06M |
Total Debt | 3.23M |
Net Cash | 56.83M |
Net Cash Per Share | $1.38 |
Equity (Book Value) | 51.64M |
Book Value Per Share | 1.25 |
Working Capital | 51.72M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -46.50M |
Capital Expenditures | n/a |
Free Cash Flow | -46.50M |
FCF Per Share | -$1.13 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -608.94% |
Pretax Margin | -555.23% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
SPRB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -20.12% |
Shareholder Yield | -20.12% |
Earnings Yield | -238.65% |
FCF Yield | -281.44% |
Analyst Forecast
The average price target for SPRB is $2.17, which is 442.50% higher than the current price. The consensus rating is "Hold".
Price Target | $2.17 |
Price Target Difference | 442.50% |
Analyst Consensus | Hold |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | 14.74% |
EPS Growth Forecast (5Y) | -13.53% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SPRB has an Altman Z-Score of -3.25 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.25 |
Piotroski F-Score | 4 |